"NIH has been working on Ebola vaccines since 2001. It's not like we suddenly woke up and thought, 'Oh my gosh, we should have something ready here,'" he said. "Frankly, if we had not gone through our 10-year slide in research support, we probably would have had a vaccine in time for this that would've gone through clinical trials and would have been ready."
As the Daily Mail pointed out, though, "overall NIH funding sits at $30.15 billion this year – up from $17.84 billion in 2000." And the NIH found creative uses for their funds.
Read the rest here...